ATE345277T1 - Injizierbare pharmazeutische suspension in einer phiole mit zwei kammern - Google Patents

Injizierbare pharmazeutische suspension in einer phiole mit zwei kammern

Info

Publication number
ATE345277T1
ATE345277T1 AT03793140T AT03793140T ATE345277T1 AT E345277 T1 ATE345277 T1 AT E345277T1 AT 03793140 T AT03793140 T AT 03793140T AT 03793140 T AT03793140 T AT 03793140T AT E345277 T1 ATE345277 T1 AT E345277T1
Authority
AT
Austria
Prior art keywords
formulation
gaseous medium
chamber
injectable pharmaceutical
medium
Prior art date
Application number
AT03793140T
Other languages
English (en)
Inventor
Steven K Macleod
Original Assignee
Pharmacia Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Corp filed Critical Pharmacia Corp
Application granted granted Critical
Publication of ATE345277T1 publication Critical patent/ATE345277T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2093—Containers having several compartments for products to be mixed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D25/00—Details of other kinds or types of rigid or semi-rigid containers
    • B65D25/02—Internal fittings
    • B65D25/04—Partitions
    • B65D25/08—Partitions with provisions for removing or destroying, e.g. to facilitate mixing of contents
    • B65D25/082—Partitions with provisions for removing or destroying, e.g. to facilitate mixing of contents the partition being in the form of a plug or the like which is removed by increasing or decreasing the pressure within the container
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1406—Septums, pierceable membranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2006—Piercing means
    • A61J1/201—Piercing means having one piercing end
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/202—Separating means
    • A61J1/2041—Separating means having removable plugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2096—Combination of a vial and a syringe for transferring or mixing their contents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Mechanical Engineering (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Details Of Rigid Or Semi-Rigid Containers (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
AT03793140T 2002-08-21 2003-08-20 Injizierbare pharmazeutische suspension in einer phiole mit zwei kammern ATE345277T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40498802P 2002-08-21 2002-08-21

Publications (1)

Publication Number Publication Date
ATE345277T1 true ATE345277T1 (de) 2006-12-15

Family

ID=31946796

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03793140T ATE345277T1 (de) 2002-08-21 2003-08-20 Injizierbare pharmazeutische suspension in einer phiole mit zwei kammern

Country Status (10)

Country Link
US (1) US7387623B2 (de)
EP (1) EP1545994B1 (de)
JP (1) JP4416653B2 (de)
AT (1) ATE345277T1 (de)
AU (1) AU2003265511A1 (de)
CA (1) CA2494825C (de)
DE (1) DE60309731T2 (de)
ES (1) ES2273078T3 (de)
NO (1) NO328187B1 (de)
WO (1) WO2004018312A1 (de)

Families Citing this family (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7275640B2 (en) * 2004-02-05 2007-10-02 Boston Scientific Scimed, Inc. Packaging for imparting anti-microbial properties to a medical device
WO2005112634A2 (en) * 2004-05-13 2005-12-01 Talamonti Anthony R Medical treatment kit and methods of use thereof
GB2414399B (en) * 2004-05-28 2008-12-31 Cilag Ag Int Injection device
GB2414775B (en) * 2004-05-28 2008-05-21 Cilag Ag Int Releasable coupling and injection device
GB2414402B (en) * 2004-05-28 2009-04-22 Cilag Ag Int Injection device
GB2414403B (en) * 2004-05-28 2009-01-07 Cilag Ag Int Injection device
GB2414409B (en) * 2004-05-28 2009-11-18 Cilag Ag Int Injection device
GB2414405B (en) * 2004-05-28 2009-01-14 Cilag Ag Int Injection device
GB2414400B (en) * 2004-05-28 2009-01-14 Cilag Ag Int Injection device
GB2414404B (en) 2004-05-28 2009-06-03 Cilag Ag Int Injection device
GB2414406B (en) 2004-05-28 2009-03-18 Cilag Ag Int Injection device
GB2414401B (en) 2004-05-28 2009-06-17 Cilag Ag Int Injection device
EP1819322A2 (de) * 2004-12-02 2007-08-22 Wyeth a Corporation of the State of Delaware Formulierungen von substituierten benzoxazolen
EA013433B1 (ru) * 2005-02-15 2010-04-30 Элан Фарма Интернэшнл Лтд. Аэрозольные и впрыскиваемые рецептуры лекарственных препаратов бензодиазепина, состоящего из наночастиц
GB2424836B (en) * 2005-04-06 2010-09-22 Cilag Ag Int Injection device (bayonet cap removal)
GB2424837B (en) * 2005-04-06 2010-10-06 Cilag Ag Int Injection device
GB2424835B (en) * 2005-04-06 2010-06-09 Cilag Ag Int Injection device (modified trigger)
GB2427826B (en) 2005-04-06 2010-08-25 Cilag Ag Int Injection device comprising a locking mechanism associated with integrally formed biasing means
GB2425062B (en) * 2005-04-06 2010-07-21 Cilag Ag Int Injection device
GB2424838B (en) * 2005-04-06 2011-02-23 Cilag Ag Int Injection device (adaptable drive)
ES2340936T3 (es) 2005-08-30 2010-06-11 Cilag Gmbh International Montaje de aguja para un sistema de jeringa precargada.
US20070074980A1 (en) * 2005-09-02 2007-04-05 Bankoski Brian R Implant rehydration packages and methods of use
US20110098656A1 (en) * 2005-09-27 2011-04-28 Burnell Rosie L Auto-injection device with needle protecting cap having outer and inner sleeves
CN101478946B (zh) 2006-05-25 2013-11-06 拜耳医药保健有限公司 重构装置
GB2438593B (en) 2006-06-01 2011-03-30 Cilag Gmbh Int Injection device (cap removal feature)
GB2438590B (en) 2006-06-01 2011-02-09 Cilag Gmbh Int Injection device
GB2438591B (en) * 2006-06-01 2011-07-13 Cilag Gmbh Int Injection device
US20080077116A1 (en) * 2006-09-12 2008-03-27 Rosemary Dailey Container for intravenous fluids
RS52657B (sr) * 2006-09-29 2013-06-28 Infa S.A. Sistem pakovanja za farmaceutske smeše i komplet za intravensku primenu
CA2697160A1 (en) * 2007-08-21 2009-02-26 Harbor Biosciences, Inc. Stabilized therapeutic compositions and formulations
US20090084804A1 (en) * 2007-10-01 2009-04-02 Hospira, Inc. Snap-over port cap
US8091727B2 (en) * 2007-11-08 2012-01-10 Hospira, Inc. Snap-over clamshell protective port cap
KR20100099292A (ko) 2007-12-19 2010-09-10 얀센 파마슈티카 엔.브이. 장기 작용성 주사가능 팔리페리돈 에스테르와 관련된 투여 요법
GB2461086B (en) * 2008-06-19 2012-12-05 Cilag Gmbh Int Injection device
GB2461087B (en) * 2008-06-19 2012-09-26 Cilag Gmbh Int Injection device
GB2461084B (en) * 2008-06-19 2012-09-26 Cilag Gmbh Int Fluid transfer assembly
GB2461085B (en) 2008-06-19 2012-08-29 Cilag Gmbh Int Injection device
GB2461088B (en) * 2008-06-19 2012-09-26 Cilag Gmbh Int Injection device
GB2461089B (en) * 2008-06-19 2012-09-19 Cilag Gmbh Int Injection device
AR076721A1 (es) * 2009-06-02 2011-06-29 Sanofi Aventis Deutschland Modulo medicinal con sistema integral de distribucion de flujo
TWI438009B (zh) * 2010-02-19 2014-05-21 Teikoku Pharma Usa Inc 紫杉烷前－乳劑調配物及其製造與使用之方法
SG185389A1 (en) 2010-05-03 2012-12-28 Teikoku Pharma Usa Inc Non-aqueous taxane pro-emulsion formulations and methods of making and using the same
EP2608826A2 (de) * 2010-08-27 2013-07-03 Sanofi-Aventis Deutschland GmbH Arzneimittelhaltiges modul mit integriertem flussverteilungssystem für eine injektionsvorrichtung
TWI577377B (zh) * 2010-09-16 2017-04-11 Ｖｉｉｖ醫療保健公司 醫藥組合物
WO2013070656A1 (en) * 2011-11-07 2013-05-16 Navinta Llc Sustained release suspension preparation for dextromethorphan
WO2013095320A1 (en) * 2011-12-23 2013-06-27 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Flurbiprofen formulations
US20140371318A1 (en) * 2011-12-23 2014-12-18 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Orally-disintegrating formulations of flurbiprofen
US20140377343A1 (en) * 2011-12-23 2014-12-25 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Formulations of flurbiprofen and diacerein
WO2013100882A2 (en) * 2011-12-27 2013-07-04 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Combinations of diacerein and non-steroidal inflammation drugs
EP2797583B1 (de) * 2011-12-27 2015-09-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Kombinierte pharmazeutische formulierung mit diacerein
AU2012360048B2 (en) 2011-12-29 2017-05-25 Omrix Biopharmaceuticals Ltd. Method and device for fast dissolution of solid protein composition
USD674104S1 (en) * 2012-03-23 2013-01-08 Fairchild Sabrina S Baby bottle with formula pouch
JO3685B1 (ar) 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
US20160030723A1 (en) * 2013-03-15 2016-02-04 Lannett Company, Inc. Multi-Chamber Anesthetic Delivery System
GB2515038A (en) 2013-06-11 2014-12-17 Cilag Gmbh Int Injection device
GB2515032A (en) 2013-06-11 2014-12-17 Cilag Gmbh Int Guide for an injection device
GB2515039B (en) 2013-06-11 2015-05-27 Cilag Gmbh Int Injection Device
GB2517896B (en) 2013-06-11 2015-07-08 Cilag Gmbh Int Injection device
GB201313368D0 (en) * 2013-07-26 2013-09-11 Xstalbio Ltd Novel Reconstitution devices
ES2802976T3 (es) * 2013-09-10 2021-01-22 Fresh Cut Dev Llc Pulverizador de buprenorfina sublingual
US10722510B2 (en) 2014-07-08 2020-07-28 Hikma Pharmaceuticals Usa Inc. Liquid naloxone spray
US10617686B2 (en) 2014-07-08 2020-04-14 Hikma Pharmaceuticals Usa Inc. Liquid naloxone spray
CA2954370A1 (en) 2014-07-08 2016-01-14 Insys Pharma, Inc. Sublingual naloxone spray
WO2016036588A1 (en) * 2014-09-03 2016-03-10 Merck Sharp & Dohme Corp. Pharmaceutical suspensions containing etoricoxib
US9763892B2 (en) 2015-06-01 2017-09-19 Autotelic Llc Immediate release phospholipid-coated therapeutic agent nanoparticles and related methods
US11229702B1 (en) 2015-10-28 2022-01-25 Coherus Biosciences, Inc. High concentration formulations of adalimumab
US11135154B2 (en) 2016-03-02 2021-10-05 Teva Pharmaceutical Industries Ltd. Medroxyprogesterone acetate injectable compositions and methods of use
US11071782B2 (en) * 2016-04-20 2021-07-27 Coherus Biosciences, Inc. Method of filling a container with no headspace
US20200281939A1 (en) * 2017-09-07 2020-09-10 Teva Pharmaceutical Industries Ltd. Medroxyprogesterone acetate injectable compositions and methods of use
WO2019048906A1 (en) * 2017-09-07 2019-03-14 Teva Pharmaceutical Industries Ltd. INJECTABLE COMPOSITIONS OF MEDROXYPROGESTERONE ACETATE AND METHODS OF USE
AR115850A1 (es) * 2018-07-27 2021-03-03 H Hoffmann La Roche Ag Método para llenar recipientes con al menos un producto farmacéutico desgasificado y dispositivos de llenado para productos farmacéuticos
WO2020049521A1 (en) 2018-09-07 2020-03-12 Teva Pharmaceutical Industries Ltd. Medroxyprogesterone acetate injectable compositions and methods of use
MX2018011142A (es) 2018-09-13 2019-10-10 Federico Amezcua Amezcua Combinacion farmaceutica sinergica de un inhibidor selectivo de la ciclooxigenasa 2 y un derivado de antraquinona.
JP7467438B2 (ja) * 2018-10-18 2024-04-15 メルク・シャープ・アンド・ドーム・エルエルシー 抗ｒｓｖ抗体の製剤及びその使用方法
CN113015748B (zh) 2018-10-31 2025-12-12 默沙东有限责任公司 抗人pd-1抗体晶体及其使用方法
CN113316458B (zh) 2018-11-07 2024-08-02 默沙东有限责任公司 抗lag3抗体和抗pd-1抗体的共制剂
US20220287914A1 (en) * 2021-03-10 2022-09-15 Carol L. Ovans Cone-Shaped Bottle Insert
EP4608441A1 (de) 2022-10-27 2025-09-03 Pfizer Inc. Immunogene zusammensetzungen gegen influenza und rsv
EP4630049A1 (de) 2022-12-11 2025-10-15 Pfizer Inc. Immunogene zusammensetzungen gegen influenza und rsv
CN115813855A (zh) * 2023-02-03 2023-03-21 苏州欧康维视生物科技有限公司 一种低浓度的阿托品药物产品及其制造方法
KR102830788B1 (ko) * 2023-03-22 2025-07-04 한국섬유소재연구원 염색물의 아릴아민 추출 시험용 염색물 시험편 용기 및 그 시험편 용기를 이용한 염색물 시험편의 아릴아민 추출 시험장치
WO2025186719A1 (en) 2024-03-06 2025-09-12 Pfizer Inc. Immunogenic compositions and uses thereof
US12343427B1 (en) * 2024-04-23 2025-07-01 Nivagen Pharmaceuticals, Inc. Stable intravenous diltiazem hydrochloride formulation and use thereof
WO2025230305A1 (ko) * 2024-04-30 2025-11-06 (주)메디톡스 담즙산 또는 이의 유도체를 포함하는 조성물 및 이를 포함하는 약학 패키지

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3087638A (en) * 1961-12-15 1963-04-30 Abbott Lab Closure assembly
US3464414A (en) 1963-07-31 1969-09-02 Upjohn Co Mixing vial construction
US3457348A (en) 1966-06-27 1969-07-22 American Cyanamid Co Stable syringeable suspensions of parenteral drugs in complex floc form
US4089432A (en) * 1977-05-06 1978-05-16 The Upjohn Company Vial and closure
NO165013C (no) * 1977-09-14 1990-12-12 Pemberton Sintermatic Fremgangsmaate og apparat til fremstilling av kjoett eller kjoettlignende produkter.
US4258845A (en) 1979-11-20 1981-03-31 The Upjohn Company Activator closure for two-compartment vial
US4614267A (en) 1983-02-28 1986-09-30 Abbott Laboratories Dual compartmented container
US4871354A (en) 1986-07-24 1989-10-03 The West Company Wet-dry bag with lyphozation vial
US5336180A (en) 1990-04-24 1994-08-09 Science Incorporated Closed drug delivery system
SE9201246D0 (sv) * 1992-04-21 1992-04-21 Kabi Pharmacia Ab Injection cartridge arrangement
JPH05317383A (ja) 1992-05-19 1993-12-03 Nissho Corp 薬剤容器との連通手段を備えた溶解液容器
US5385546A (en) 1992-06-24 1995-01-31 Science Incorporated Mixing and delivering system
US5335773A (en) 1993-07-02 1994-08-09 Habley Medical Technology Corporation Multi-pharmaceutical storage, mixing and dispensing vial
US5462526A (en) * 1993-09-15 1995-10-31 Mcgaw, Inc. Flexible, sterile container and method of making and using same
DE19847968A1 (de) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Verschlußkappe und Behälter als Zweikammer-Kartusche für Vernebler zur Erzeugung von Aerosolen
EP1251742A4 (de) * 1999-10-18 2004-10-06 Dial Corp Vorrichtung und verfahren zur herstellung von hüllenlosen würsten
US6495534B2 (en) 2000-05-15 2002-12-17 Pharmacia & Upjohn Spa Stabilized aqueous suspensions for parenteral use
US20030165568A1 (en) 2000-05-15 2003-09-04 Giuseppe Colombo Stabilized steroidal suspension
JP2004337318A (ja) * 2003-05-14 2004-12-02 Otsuka Pharmaceut Factory Inc 医療用複室容器及びその製造方法

Also Published As

Publication number Publication date
WO2004018312A1 (en) 2004-03-04
EP1545994B1 (de) 2006-11-15
AU2003265511A1 (en) 2004-03-11
DE60309731D1 (de) 2006-12-28
US7387623B2 (en) 2008-06-17
JP2005536285A (ja) 2005-12-02
CA2494825C (en) 2009-02-17
NO20051372L (no) 2005-03-16
JP4416653B2 (ja) 2010-02-17
NO328187B1 (no) 2009-12-28
CA2494825A1 (en) 2004-03-04
ES2273078T3 (es) 2007-05-01
DE60309731T2 (de) 2007-06-28
EP1545994A1 (de) 2005-06-29
US20040039366A1 (en) 2004-02-26

Similar Documents

Publication Publication Date Title
ATE345277T1 (de) Injizierbare pharmazeutische suspension in einer phiole mit zwei kammern
EA200200431A1 (ru) Фармацевтические композиции, обеспечивающие повышенные концентрации лекарства
EP1243524A3 (de) Pharmazeutisches Kit fÜr sauerstoffempfindliche Medikamente
PA8575701A1 (es) Preparaciones acidas de insulina con estabilidad mejorada
UA26303A1 (uk) Фармацевтичhа композиція, яка має імуhосупресорhу та аhтимікробhу активhість
CO5070580A1 (es) Formulacion farmaceutica para aerosoles con dos o mas sustancias activas
ES2163511T3 (es) Preparacion farmaceutica conteniendo glucagon.
CL2010000816A1 (es) Formulacion adecuada para administracion subcutanea que comprende al menos 100 mg/ml de ctlaig, un azucar, y un portador acuoso farmaceuticamente estable; articulo de fabricacion que comprende al menos un recipiente que contiene la formulacion antes mencionada. (divisional solicitud n° 3597-06)
CL2009001899A1 (es) Composicion farmaceutica que comprende: i) un antagonista del receptor de at1 o una sal, ii) un sensibilizante a la insulina o una sal y iii) un vehiculo farmaceuticamente aceptable; uso para la prevencion, demora de progreso o tratamiento de hipertension, diabetes, entre otras (div. sol. 2034-01).
ES2129048T3 (es) Composicion estabilizada de hormona paratiroide.
GB2380675A (en) Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives
SV2002000969A (es) Composicion parenteral reconstituible
CO5011053A1 (es) Procedimiento para la produccion de una forma de dosificacion solida que contiene carvedilol e hidroclorotiazida y formas farmaceuticas obtenidas por dicho procedimiento
ATE233305T1 (de) Verpackungsmaterial mit aktiver auslösung
AR025052A1 (es) Derivados de 2-dialquilaminoalquilbifenilo sustituidos, procedimiento para su preparacion, medicamentos que contienen estos compuestos y el uso de estoscompuestos para la preparacion de medicamentos.
MXPA02012160A (es) Composiciones medicinales las cuales contienen derivados de propenona.
PE20001326A1 (es) Composicion farmaceutica que comprende cefuroxima-axetil, polimero y/o adsorbente
HRP20060089B1 (en) Method for the stabilization of atorvastatin
ATE253940T1 (de) Stabile lösung von calcitriol zum verpacken in phiolen
HRP20050342B1 (hr) Farmaceutska formulacija olanzapina
CO4830457A1 (es) Preparados efervescentes
NO960098L (no) Preparat i form av matriks-innesluttede små perler
ATE400256T1 (de) Pharmazeutische zusammensetzung mit einem kationischen hilfsmittel
CA2344686A1 (en) High purity composition comprising (7.alpha.,17.alpha.)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one
NO980785L (no) Sulfonamidsubstituerte kondenserte 7-ringforbindelser, deres anvendelse som medikament samt farmasöytiske preparater inneholdende forbindelsene

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties